Thoracic Specimen Registry for Lung Cancer and Other Thoracic Diseases
This registry aims to collect blood, tissue, and fluid samples from people with thoracic diseases (conditions affecting the chest area), including lung cancer and those who have had lung transplants. The goal is to create a comprehensive collection of these samples to support research into the causes, early detection, treatment, and outlook for these conditions. Researchers hope to use these samples to discover new ways to screen, diagnose, and treat thoracic diseases. You may be able to join if you are over 18 years old and have a presumed or known thoracic disease. The study plans to enroll 7000 participants and will collect samples over approximately 10 years. The current recruitment status is unclear.
- Study design
- This is an observational study that plans to enroll 7000 participants. It is not a treatment study but focuses on collecting samples for future research.
- What's involved
- You would provide blood, tissue (from surgeries or biopsies), and fluid samples (like from the lungs or around the lungs). These samples will be stored for research.
- Compensation
- Not stated in the trial record.
- Follow-up
- Samples will be collected and stored through study completion, which is approximately 10 years.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Thoracic Specimen Registry
At a glance
Conditions
Where it's being run
1 sites across 1 statesStudy leadership
- Eric Edell, MD · PRINCIPAL_INVESTIGATOR · Mayo Clinic
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
What this trial measures
- Thoracic Specimen RepositoryThrough study completion, approximately 10 years
Number of thoracic specimens collected